Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion type Assertion NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_head.
- NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion description "[In patients with advanced colorectal carcinoma, those with tumors with high levels of NP-1 staining showed a significantly higher incidence of lymph node (73.0%) or liver (86.2%) metastasis, greater microvessel density (MVD) (60.4/field), greater number of proliferating carcinoma cells (48.6%), and lesser number of apoptotic carcinoma cells (5.70 per thousand) than those with tumors with low levels of NP-1 staining (lymph node, 56.9%; liver, 59.8%; MVD, 47.8/field; proliferating cells, 42.0%; apoptosis, 8.44 per thousand).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_provenance.
- NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion evidence source_evidence_literature NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_provenance.
- NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion SIO_000772 16773190 NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_provenance.
- NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion wasDerivedFrom befree-20140225 NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_provenance.
- NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_assertion wasGeneratedBy ECO_0000203 NP746550.RAA0nYJnBgbYhOnqOYGLy2NSsBoDWxz5xLYPVF0ZZg24g130_provenance.